Zika virus dumbbell-1 structure is critical for sfRNA presence and cytopathic effect during infection.
RNA
Zika virus
apoptosis
flavivirus
sfRNA
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
31 Aug 2023
31 Aug 2023
Historique:
pubmed:
7
7
2023
medline:
7
7
2023
entrez:
7
7
2023
Statut:
ppublish
Résumé
All flaviviruses contain conserved RNA structures in the 3' untranslated region (3' UTR) that are important for flavivirus RNA replication, translation, and pathogenesis. Flaviviruses like Zika virus (ZIKV) contain multiple conserved RNA structures in the viral 3' UTR, including the structure known as dumbbell-1 (DB-1). Previous research has shown that the DB-1 structure is important for flavivirus positive-strand genome replication, but the functional role of the flavivirus DB-1 structure and the mechanism by which it contributes to viral pathogenesis are not known. Using the recently solved flavivirus DB RNA structural data, we designed two DB-1 mutant ZIKV infectious clones, termed ZIKV-TL.PK and ZIKV-p.2.5', which disrupt DB-1 tertiary folding. We found that viral positive-strand genome replication of both ZIKV DB-1 mutant clones is similar to wild-type (WT) ZIKV, but ZIKV DB-1 mutants exhibit significantly decreased cytopathic effect due to reduced caspase-3 activation. We next show that ZIKV DB-1 mutants exhibit decreased levels of sfRNA species compared to ZIKV-WT during infection. However, ZIKV DB-1 mutant 3' UTRs exhibit unchanged sfRNA biogenesis following XRN1 degradation
Identifiants
pubmed: 37417764
doi: 10.1128/mbio.01108-23
pmc: PMC10470596
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0110823Subventions
Organisme : NIAID NIH HHS
ID : R01 AI153724
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI153724
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI133348
Pays : United States
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
mBio. 2019 Jan 8;10(1):
pubmed: 30622191
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
PLoS Negl Trop Dis. 2016 Oct 5;10(10):e0005048
pubmed: 27706161
Front Vet Sci. 2021 Aug 02;8:703147
pubmed: 34409089
J Virol. 2020 Oct 14;94(21):
pubmed: 32847848
J Virol. 2000 Apr;74(7):3020-8
pubmed: 10708416
Virus Res. 2015 Aug 3;206:108-19
pubmed: 25683510
Emerg Infect Dis. 2015 Oct;21(10):1885-6
pubmed: 26401719
Cell Host Microbe. 2008 Dec 11;4(6):579-91
pubmed: 19064258
J Virol. 2012 May;86(10):5708-18
pubmed: 22379089
Annu Rev Med. 2016;67:387-404
pubmed: 26515983
J Virol. 2000 Apr;74(7):3011-9
pubmed: 10708415
Nucleic Acids Res. 2013 May;41(9):5075-89
pubmed: 23531545
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Nat Med. 2017 Jun;23(6):763-767
pubmed: 28394328
PLoS Negl Trop Dis. 2019 Mar 28;13(3):e0007213
pubmed: 30921321
Lancet. 2015 Jul 18;386(9990):243-4
pubmed: 26194519
Virology. 2014 Jan 5;448:15-25
pubmed: 24314632
J Hyg (Lond). 1979 Oct;83(2):213-9
pubmed: 489960
Science. 2016 Dec 2;354(6316):1148-1152
pubmed: 27934765
Cell Host Microbe. 2018 Dec 12;24(6):875-886.e5
pubmed: 30472207
RNA. 2021 Jan;27(1):54-65
pubmed: 33004436
Cell Microbiol. 2017 May;19(5):
pubmed: 28273394
PLoS Pathog. 2014 Jul 03;10(7):e1004242
pubmed: 24992036
Viruses. 2020 Oct 18;12(10):
pubmed: 33080971
Nat Commun. 2017 Sep 22;8(1):676
pubmed: 28939807
Vaccine. 2018 Jun 7;36(24):3460-3467
pubmed: 29752023
Lancet. 2017 Nov 4;390(10107):2099-2109
pubmed: 28647173
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
J Virol. 2003 Nov;77(21):11436-47
pubmed: 14557629
Sci Adv. 2022 Dec 2;8(48):eadd8095
pubmed: 36449607
Nucleic Acids Res. 2021 Jul 9;49(12):7122-7138
pubmed: 34133732
Clin Microbiol Rev. 2016 Jul;29(3):487-524
pubmed: 27029595
J Virol. 2016 Dec 16;91(1):
pubmed: 27795432
Vaccine. 2011 Sep 23;29(42):7242-50
pubmed: 21781997
J Virol. 2020 Aug 31;94(18):
pubmed: 32581095
Am J Trop Med Hyg. 2001 Nov;65(5):405-13
pubmed: 11716091
Antiviral Res. 2018 Nov;159:13-25
pubmed: 30217649
Vaccine. 2008 Feb 6;26(6):817-28
pubmed: 18191005
PLoS One. 2014 Oct 13;9(10):e109442
pubmed: 25310102
Nat Commun. 2020 May 5;11(1):2205
pubmed: 32371874
Elife. 2014 Apr 01;3:e01892
pubmed: 24692447
J Infect Dis. 2013 Mar 15;207(6):957-65
pubmed: 23329850
J Virol. 2010 Nov;84(21):11407-17
pubmed: 20719943
Front Microbiol. 2017 Apr 03;8:546
pubmed: 28421048
J Virol. 1998 Jan;72(1):73-83
pubmed: 9420202
Cell. 2009 Feb 20;136(4):763-76
pubmed: 19239894
Science. 2015 Oct 9;350(6257):217-21
pubmed: 26138103
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):521-34
pubmed: 12995441